Intravenous Versus Intra-peritoneal Dexamethasone on the Incidence of Postoperative Nausea and Vomiting
Not Applicable
Completed
- Conditions
- Postoperative Nausea and Vomiting
- Interventions
- Drug: Intraperitoneal Dexamesathone
- Registration Number
- NCT02947672
- Lead Sponsor
- Assiut University
- Brief Summary
Effect of intravenous versus intra-peritoneal dexamethasone on the incidence of postoperative nausea and vomiting following Laparoscopic gynecological surgeries.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
- Adult Female patients
- American society of anesthesiologist class I & II
- Undergoing Laparoscopic gynecological surgeries
Exclusion Criteria
- Patient refusal to participate in the study
- Patients with coagulopathy or under anticoagulation therapy.
- Infection near the site of needle insertion.
- Body mass index > 40kg/m2
- Patients with any neurological or neuromuscular disorder or history of seizures.
- Known allergy to any drug used in the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intravenous dexamethasone Intravenous Dexamethasone 50 patients will receive intravenous dexamethasone Intra peritoneal dexamethasone Intraperitoneal Dexamesathone 50 patients will receive intraperitoneal dexamethasone
- Primary Outcome Measures
Name Time Method Postoperative nausea and vomiting (PONV) 24 hours PONV will be measured by using Verbal Descriptive Scale
- Secondary Outcome Measures
Name Time Method Pain 24 hours Pain will be assessed by using visual analogue scale
Trial Locations
- Locations (1)
Assiut University Hospital
🇪🇬Assiut, Egypt